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Abstract
DNA double strand breaks (DSBs) trigger a variety of cellular signaling processes, collectively 
termed the DNA-damage response (DDR), that are primarily regulated by protein kinase ataxia-
telangiectasia mutated (ATM). Among DDR activated processes, the repair of DSBs by non-
homologous end joining (NHEJ) is essential. The proper coordination of NHEJ factors is mainly 
achieved through phosphorylation by an ATM-related kinase, the DNA-dependent protein kinase 
catalytic subunit (DNA-PKcs), although the molecular basis for this regulation has yet to be fully 
elucidated. In this study we identify the major NHEJ DNA polymerase, DNA polymerase lambda 
(Polλ), as a target for both ATM and DNA-PKcs in human cells. We show that Polλ is efficiently 
phosphorylated by DNA-PKcs in vitro and predominantly by ATM after DSB induction with 
ionizing radiation (IR) in vivo. We identify threonine 204 (T204) as a main target for ATM/DNA-
PKcs phosphorylation on human Polλ, and establish that its phosphorylation may facilitate the 
repair of a subset of IR-induced DSBs and the efficient Polλ-mediated gap-filling during NHEJ. 
Molecular evidence suggests that Polλ phosphorylation might favor Polλ interaction with the 
DNA-PK complex at DSBs. Altogether, our work provides the first demonstration of how Polλ is 
regulated by phosphorylation to connect with the NHEJ core machinery during DSB repair in 
human cells.
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1. Introduction
DNA double-strand breaks (DSBs) constitute one of the most harmful types of damage 
human cells may undergo, since, when improperly repaired, can generate genomic instability 
that contributes to development of cancer and human syndromes such as ataxia 
telangiectasia (AT), Nijmegen breakage syndrome or the Lig4 syndrome [1]. DSBs trigger 
intracellular signaling processes, collectively termed the DNA-damage response (DDR), that 
includes cell-cycle checkpoint arrest and repair responses [2]. Protein kinase ataxia-
telangiectasia mutated (ATM), a member of the Phosphatidylinositol 3-Kinase-related 
Kinases (PIKKs) family, acts as an apical activator of DDR modifying hundreds of proteins 
at specific sites [3]. The fastest pathway for the repair of DSBs is non-homologous end 
joining (NHEJ), a process that trims and subsequently reconnects broken ends, while 
requiring only minimal or even null complementarity. Despite its status as the principal DSB 
repair pathway in most cell cycle stages [4], NHEJ possesses the disadvantage of being 
inherently error-prone. Indeed, its repair activity can lead to chromosomal translocations [5]. 
Recent evidence suggests that NHEJ is more complex than a simple cut-and-paste process, 
with the degree of complexity depending directly on the nature of the DNA ends to be joined 
[6,7]. In this variable scenario, NHEJ shows an exceptional ability to deal with the wide 
range of DSBs generated in vivo thanks to the many protein factors and enzymatic activities 
involved in the process [8]. In the first step of NHEJ, DSBs are recognized by the Ku70/
Ku80 complex, which protects DNA ends from degradation and acts as a scaffold for the 
recruitment of other required NHEJ factors [9]. DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs) is the first protein recruited to DSBs by the Ku70/Ku80 heterodimer, 
through an interaction with the C-terminus of Ku80, to form the DNA-PK complex [10]. 
Binding to DNA promotes activation of DNA-PKcs kinase activity, which is essential for the 
precise coordination of NHEJ machinery according to the configuration of DSB ends. Once 
activated, DNA-PKcs can phosphorylate a number of NHEJ factors, including Ku70, Ku80, 
Artemis, XRCC4, the XRCC4-like factor (XLF), and DNA ligase IV [reviewed in 11]. Many 
of these targets have been well described and their phosphorylation by DNA-PKcs is not 
required for successful NHEJ in vivo [12-14]. To date, DNA-PKcs itself is the only 
unequivocally defined functionally relevant target of its own kinase activity [15-19]. 
Following completion of its task at the DSB, DNA-PKcs is autophosphorylated leading to a 
conformational change that frees the DNA ends and allows NHEJ to proceed [18,19]. As 
DSBs produced in vivo usually have a wide variety of DNA ends, including different 
configurations and chemical modifications [7], they cannot be directly ligated and must be 
processed prior to the restoration of DNA integrity. This processing often includes 
nucleolytic resection of the damaged nucleotides, as well as DNA polymerization to replace 
the resected DNA and to fill the small gaps generated. Specialized DNA gap-filling 
synthesis associated with NHEJ in mammalian cells is mainly carried out by PolX family 
DNA polymerases mu (Polμ) and lambda (Polλ). The participation of Polμ and Polλ in 
NHEJ is facilitated by their recruitment to DSBs through the interaction with DNA-bound 
NHEJ core factors, which is primarily mediated by their N-terminal BRCT domain [20-22]. 
Although both polymerases are able to perform gap-filling reactions, they differ significantly 
in their optimal substrate and, when active on the same substrate, they often generate distinct 
products [23,24]. Of the two, Polλ is uniquely effective when 3′-termini are double-
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stranded and able to completely fill-in gaps larger than 1 nt [24]. This distinguishing 
capability is due in part to its ability to scrunch the next-to-be copied template nucleotides in 
such substrates [25]. Although the physiological role of Polλ in repair of DSBs by NHEJ 
during VDJ recombination has been established [26], little is known about its regulation 
during the repair process.
In this work, we identify the phosphorylation of human Polλ by the DDR-related kinases 
ATM and DNA-PKcs as a novel mechanism of NHEJ regulation in human cells. We show 
that Polλ is efficiently phosphorylated by DNA-PKcs in vitro and we identify threonine 204 
(T204), located in the linker serine/proline-rich (S/P-rich) domain, as a main target for such 
modification. Interestingly, T204 phosphorylation after DSB induction with ionizing 
radiation in vivo is predominantly performed by ATM, and may facilitate Polλ-mediated 
gap-filling DNA synthesis during NHEJ. Our data suggest that T204 phosphorylation might 
induce conformational changes in Polλ that stimulate its interaction with DNA-bound NHEJ 
core factors. In support of this finding, we show that the association of Polλ with Ku80 
diminishes after DSBs formation in vivo when T204 phosphorylation does not occur 
properly. Overall, our work describes a novel mechanism of Polλ regulation and contributes 
to the understanding of the molecular basis of the NHEJ repair process in human cells.
2. Materials and Methods
2.1 Cell culture
Human embryonic kidney 293 cells (293T), human osteosarcoma cells (U2OS) and human 
melanoma cell lines G361 and HT144 (a kind gift from Dr. Y. Shiloh, Sackler School of 
Medicine, Tel Aviv University, Israel) were cultured in DMEM medium (Sigma) 
supplemented with 10% fetal bovine serum (Sigma), 2 mM L-glutamine (Sigma) and 
antibiotics (100 units/ml penicillin, 100 μg/ml streptomycin) at 37°C in a humidified 
atmosphere containing 5% CO2. Mouse embryonic fibroblast cells were cultured as 
previously described [24].
2.2 Plasmids and RNA interference
The cDNA encoding human POLL was amplified with oligonucleotides sBglII (5′-ttgatc 
AGATCTtatggatcccaggggtatcttg-3′) and asXbaI (5′-ttgatcTCTAGAtaaccagtcccgctc-3′) and 
the PCR product was digested with BglII and XbaI and cloned in the equally digested 
p3xFLAG-Myc-CMV Expression Vector (Sigma). POLL phospho-blocking mutants were 
generated by site-directed mutagenesis starting from the wild-type construct and using 
oligonucleotides T188A-s (5′-gcaccaaacGcccaagcccagcc-3′), T188A-as (5′-
ggctgggcttgggCgtttggtgc-3′), T204A-s (5′-ggggaagaaGcccaggttagtgc-3′) and T204A-as 
(5′-gcactaacctgggCttcttcccc-3′). Silencing of endogenous POLL was performed by using 
previously validated siRNAs [27] and two consecutive rounds of transfection with 
RNAiMAX according to manufacturer's protocol (Life Technologies). To obtain human 
POLL mutant versions (both T204A phospho-blocking and T204E phospho-mimetic 
mutants) for protein purification, site-directed mutagenesis was performed using the plasmid 
pET22b-Polλ [28] as a template with the same oligonucleotides T204A-s and T204A-as 
described above, and oligonucleotides T204E-s (5′-
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GATGATGAAGCCAGTGATGGGGAAGAAGAGCAGGTTAGTGCAGCTGATCTGGAA
GCC-3′) and T204E-as (5′-
GGCTTCCAGATCAGCTGCACTAACCTGCTCTTCTTCCCCATCACTGGCT 
TCATCATC-3′), respectively. All constructs were verified by DNA sequencing.
2.3 Immunoprecipitation and immunoblotting
For immunoprecipitations, 2.5×105 human 293T cells were seeded per well in 6-well dishes, 
cultured for 24 h and transiently transfected with p3xFLAG-Myc-CMV expression vector 
containing either wild-type POLL or POLL-T204A phospho-blocking mutant cDNAs using 
Gene Juice (Novagen) according to manufacturer's protocol. Forty-eight hours later, cells 
were either mock-irradiated or irradiated with 10 Gy of IR. At the indicated times post-
irradiation, asynchronous cultured cells were washed with cold-phosphate buffered saline 
(PBS) and collected by low speed centrifugation. Cells were lysed in 500 μL lysis buffer (20 
mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 2 mM EDTA, 1% NP-40, 1 mM 
phenylmethylsulfonyl sulfate (PMSF), protease and phosphatase inhibitor cocktails (Sigma) 
and 1 mM DTT) homogenized and incubated on ice for 30 min. Lysates were cleared by 
centrifugation at 13,000 rpm for 20 min at 4°C and input (whole cell extract) samples saved 
for subsequent analysis. Remaining supernatants were incubated with FLAG M2 
monoclonal antibody (Sigma) overnight at 4°C according to manufacturer's protocol in the 
presence of 12 U Benzonase (Millipore). Immuno-complexes were then incubated with 
Protein G-coupled Dynabeads (Life Technologies) for 4 h with end-to-end mixing at 4°C. 
Beads were washed three times in lysis buffer and bound immuno-complexes were eluted by 
boiling in Laemmli buffer at 95°C for 5 min. Proteins were resolved by 10% SDS-PAGE, 
except in the experiment described in Figure 6B, in which they were resolved by using pre-
cast 4-20% gradient SDS-PAGE gels (Biorad). Input lysate (10%) was loaded alongside 
unless otherwise stated. For the immunoprecipitation of ATM from G361/HT144 cells, 
whole cell extracts were prepared from these cell lines as described above, and they were 
incubated with a mouse monoclonal anti-ATM antibody (clone MAT3-4G10/8; Sigma). 
Immuno-complexes were then treated as described above and finally eluted and used in 
kinases assays.
For western blot analyses protein extracts were prepared as described above. When 
indicated, specific inhibitors of ATM (KU55933; ATMi, Tocris; 5 μM) and DNA-PK 
(NU7441; DNA-PKi, Tocris; 5 μM) or control vehicle (DMSO) were added to cell culture 
media 1 hour before irradiation. Proteins were resolved by 10% SDS-PAGE, except for ATM 
and DNA-PKcs immunodetection, that were resolved in pre-cast 4-20% gradient SDS-PAGE 
gels (BioRad). Then they were transferred onto Immobilon-FL PVDF membranes 
(Millipore) by using a wet-transfer system (Biorad) at 150 mA for 2 h at 4°C. For the 
Western blot described in Figure 3D (panel showing FLAG-Polλ electrophoretic mobility 
using anti-FLAG antibody) protein extracts were run on 6% polyacrylamide long (16 cm) 
gels and electrophoresis was carried out using a SE600 Hoefer electrophoresis system. 
Immunoblotting was performed according to Odyssey LI-COR Biosciences protocol. 
Briefly, membranes were blocked in Odyssey Blocking Buffer (LI-COR) and incubated 
overnight at 4°C with the primary antibodies at indicated dilution in the same blocking 
buffer supplemented with 0.1% Tween20. Primary antibodies were used at the following 
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dilution: mouse monoclonal anti-FLAG M2 (Sigma; 1/5,000), mouse anti-tubulin (Sigma; 
1/2,000), rabbit anti-Ku80 (Santa Cruz; 1/1,000), rabbit anti-XRCC4 (Santa Cruz; 1/1,000), 
rabbit anti-DNA-PKcs (Santa Cruz; 1/1,000), rabbit anti-phospho-DNA-PKcs S2056 (Cell 
Signaling; 1/2,000), rabbit anti-Polλ (Bethyl; 1/1,000), rabbit anti-phospho Polλ-Thr204 
(1/500) and rabbit anti-phospho (Ser/Thr) ATM/ATR substrate (Cell Signaling; 1/1,000). 
After washes with TBS-0.1% Tween20, membranes were incubated with the corresponding 
secondary antibodies (IRDyes 800CW for rabbit and/or 680RD for mouse primary 
antibodies, respectively 1/15,000; LI-COR Biosciences) supplemented with 0.1% Tween20. 
After washes, membranes were allowed to dry and then analyzed in Odyssey imaging 
system with the ImageStudio Odyssey CLx Software (LI-COR). Quantification of relative 
band intensities was carried out using ImageJ software.
2.4 Immunofluorescence
To analyze 53BP1 foci repair kinetics, approximately 4×104 U2OS cells were seeded onto 
sterile glass coverslips in each well of a 4-well dish, cultured for 24 h and transfected with 
the indicated siRNAs as described above. Twenty-four hours later, cells were subjected to a 
second siRNA transfection as described above and incubated for 48 additional hours. After 
this time, cells were mock irradiated or irradiated with 10 Gy, and fixed with 4% 
paraformaldehyde in PBS at different times (9, 12 and 24 h) after irradiation. Before 
immunofluorescence protocol cells were permeabilized with PBS supplemented with 0.2% 
Triton X-100 for 2 min and blocked in PBS-5% BSA for 30 min. Then, cells were incubated 
with rabbit polyclonal anti-53BP1 (Santa Cruz; 1/1,000) diluted in PBS-1% BSA. After 
washes with PBS-0.1% Tween 20, cells were incubated with the corresponding Alexa Fluor-
conjugated secondary antibody (Jackson; 1/1,000 dilution in 1% BSA-PBS) and washed 
again. Finally, cells were counterstained with 4,6 diamidino-2-phenylindole (DAPI 1 μg/ml; 
Sigma) and mounted using Vectashield mounting medium (Vector Laboratories). Samples 
were visualized using the 488-nm (Alexa 488) and 405-nm (for DAPI) lasers. Highly 
resolved z-stacks were captured using a Leyca DM6000B fluorescence microscope with a 
HCX PL APO 63x/NA 1.40 oil immersion objective. Subsequently, 3D rendering was 
performed to convert the 3D z-stacks into a 2D image, and 53BP1 foci were manually 
(double-blind) counted. Data represent means of three independent experiments, in which at 
least 50 cells were counted at each experimental condition.
For proximity ligation assays (PLA) U2OS cells were grown on sterile glass coverslips and 
transiently transfected with p3xFLAG-Myc-CMV expression vector containing either wild-
type POLL or POLL-T204A phospho-blocking mutant cDNAs using Gene Juice (Novagen) 
according to manufacturer's protocol. After 48 h cells were exposed or not to 2 Gy of IR and 
allowed to recover for 1 h. Then, cells were fixed and permeabilized as previously described. 
The PLA assay was performed with the Duolink PLA kit (Sigma) following manufacturer's 
instructions, and using mouse anti-FLAG M2 (Sigma; 1/5,000) and either rabbit anti-Ku80 
(1/1,000; Santa Cruz), rabbit anti-XRCC4 (Santa Cruz; 1/1,000) or rabbit anti-DNA-PKcs 
(1/1,000; Santa Cruz) primary antibodies. After final wash step cells were counterstained 
with DAPI and mounted as described above. Samples were visualized using the 594-nm 
(Alexa 594) and 405-nm (for DAPI) lasers. Highly resolved z-stacks were captured using a 
Leyca DM6000B fluorescence microscope with a HCX PL APO 63x/NA 1.40 oil immersion 
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objective. Subsequently, 3D rendering was performed to convert the 3D z-stacks into a 2D 
image, and PLA foci were manually (double-blind) counted. Data represent means of three 
independent experiments, in which at least 50 cells were counted at each experimental 
condition.
2.5 Generation of a phospho-specific antibody to Polλ T204
Antibodies against Polλ phosphorylated at threonine 204 were generated in rabbit using 
peptides containing phosphorylated threonine 204 (pT204) coupled to KLH according to 
standard immunization protocols. The phospho-specific antibodies were partially purified 
from serum by two sequential steps using aldehyde-activated cross-linked beaded agarose 
columns (Thermo Scientific) coupled to either the synthetic peptides containing non-
phosphorylated (npT204) or phosphorylated T204 (pT204) (Thermo Scientific) according to 
manufacturer's protocol. Antibodies were eluted using 200 mM glycine pH 2.5, neutralized 
with Tris 1M pH 8 and concentrated with centrifugal filters (Centricon 3,000 NMWL 
Ultracel YM, Millipore). Partially purified phospho-specific antibodies were pre-incubated 
for 2 h with non-phosphorylated T204 peptide (10 μg/ml) to block remaining non-phospho 
specific antibodies, and then used in immunoblotting experiments as described above.
2.6 Kinase assays
Recombinant wild-type Polλ and phospho-blocking mutants (T204A, T188A T188,204A) 
were over-expressed in E. coli BL21-pRIL and purified as previously described [28]. One 
microgram of purified proteins was used in kinase assays in vitro with either 20 units of 
human DNA-PK complex (Promega) or immunoprecipitated ATM. ATM was 
immunoprecipitated from 293T cells that were transfected with a plasmid encoding FLAG-
tagged ATM (pcDNA3.1(+)Flag-His-ATM wild-type was a gift from Dr. Michael Kastan; 
Addgene plasmid #31985 [29]). Cells were lysed with lysis buffer (50 mM Tris [pH7.4], 150 
mM NaCl, 10% glycerol, 0.2% Tween 20, 0.2% NP40, and 1 mM DTT, protease inhibitors, 
and phosphatase inhibitors) and FLAG-tagged ATM was immunoprecipitated with anti-
FLAG M2 agarose (Sigma-Aldrich) and Protein G-coupled Dynabeads (Life Technologies) 
as described above. Alternatively, ATM was immunoprecipitated from G361 (ATM-
proficient) or HT144 (ATM-deficient) cell lines using anti-ATM antibody (monoclonal Anti-
ATM Clone MAT3-4G10/8, Sigma) and Protein G-coupled Dynabeads (Life Technologies) 
as described above. Kinases assays were performed in kinase reaction buffer (50 mM Tris-
HCl pH 7.5, 10 mM MgCl2, 0.1 mM EDTA, 2 mM DTT) supplemented with 200 μM of 
ATP and double-stranded DNA. Radiolabelling assay was performed in the presence of 
[γ-32P]-ATP (0.05 μCi/μl; PerkinElmer). All reaction mixtures were incubated at 30°C for 
30 min and boiled in Laemmli buffer for 5 min before loading onto 4-20% gradient SDS-
PAGE gels (Biorad). Gels were dryed and radioactive proteins detected by phosphor-
imaging using a Fuji-gel scanner. Quantification of relative band intensities was carried out 
using ImageJ software. For kinase assay on peptide-scanning arrays, N-terminal acetylated 
overlapping dodecapeptides covering the N-terminal domains of human Polλ were 
generated by automated spot synthesis onto an amino-derivatized cellulose membrane (CNB 
Proteomics Core Facility, Proteored, Spain). Peptides were immobilized by their C-termini 
via a polyethylene glycol spacer. Overlapping peptides were spotted onto membrane so that 
they shared 10 amino acids with its adjacent peptide on the array, corresponding to a change 
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of two amino acids per peptide. The incubation of the peptide-array with human purified 
DNA-PKcs (a kind gift from Dr. Susan Lees-Miller) and [γ-32P]-ATP was performed as 
described above.
2.7 Thermal shift and partial proteolysis assays
For protein thermal shift experiments, purified human Polλ proteins (2 μg each sample) 
were mixed with PTS-Dye (Applied Biosystems) and melting profiles were obtained within 
a range of 25–99°C using a ramping rate of 0.05°C s−1 and an acquisition of 20 data points 
per degree celsius in a ViiA™7 Real-Time PCR System (Applied Biosystems). Data was 
analyzed using the Protein Thermal Shift™ Software v1.0 (Applied Biosystems). Data was 
corrected for the background signal of the buffer conditions and presented as units of 
fluorescence with respect to temperature. Melting temperatures (Tm) were determined 
according to the Boltzmann model. Error bars represent standard deviation from four 
independent replicates. For proteolysis assays purified human Polλ proteins (5 μg each 
sample) were incubated at 37°C for 120 min with 0.2 μg trypsin (Promega) in a buffer 
containing 25 mM MOPS pH 7.0, 20 mM Tris pH 8.0, 5 mM MgCl2, 8% glycerol, 80 mM 
NaCl and 2 mM DTT. Reactions were stopped by boiling in Laemmli buffer for 5 minutes at 
95°C and resolved by 10% SDS-PAGE and Coomassie blue staining.
2.8 DNA polymerization assays
Recombinant wild-type Polλ, phospho-blocking (T204A) and phospho-mimic (T204E) 
mutants were over-expressed in E. coli and purified as previously described [28]. 
Oligonucleotides used for DNA polymerization assays were purchased from Sigma and 
purified by 8M urea-20% polyacrylamide gel electrophoresis. Dideoxynucleotides (ddNTPs) 
and deoxynucleotides (dNTPs) were acquired from GE Healthcare. Oligonucleotides used as 
primers were 5′-labelled with [γ-32P]-ATP (Perkin-Elmer) and T4 polynucleotide kinase 
(New England Biolabs). For 1 nt DNA gap-filling assays, a 5′-[32P]-labelled 15-mer DNA 
primer (5′-GATCACAGTGAGTAC-3′) was hybridized to a 28-mer DNA template (5′-
AGAAGTGTATCTCGTACTCACTGTGATC-3′) and to a 12-mer DNA downstream 
molecule harboring a 5′-phosphate group (5′-AGATACACTTCT-3′). Purified Polλ (50 
nM) was incubated with 2.5 nM of the labelled 1 nt gapped DNA in a reaction mixture (20 
μl) containing MgCl2 (2.5 mM), increasing concentrations of ddGTP (0.1, 0.25, 0.5, 1, 2.5 
nM) and 1x of reaction buffer (50 mM Tris-HCl (pH 7.5), 1 mM DTT, 4% glycerol and 0.1 
mg/ml BSA). Given that Polλ does not discriminate between dNTPs and ddNTPs [30], 
ddNTPs were used for the gap-filling of 1nt-gapped substrates to ensure that polymerization 
events were restricted to a +1 nt insertion. Following 30 min of incubation at 30°C, reactions 
were stopped by adding loading buffer (95% (v/v) formamide, 10 mM EDTA, 0.1% (w/v) 
xylene cyanol and 0.1% (w/v) bromophenol blue) and the products were separated by 8M 
urea-20% polyacrylamide electrophoresis. After electrophoresis, products of extension were 
analyzed by autoradiography and gel band intensities determined by densitometry. For in 
vitro NHEJ assays, a 5′-[32P]-labelled 15-mer DNA primer (5′-
CCCTCCCTCCGCGGC-3′) was hybridized to a 11-mer DNA oligonucleotide (5′-
CGGAGGGAGGG-3′) to generate a labelled primer double stranded DNA molecule with a 
3′-overhang. A 21-mer DNA template (5′-CGCGCACTCACGTCCCTCGCC-3′) was 
hybridized to a 16-mer DNA oligonucleotide (5′-GGGACGTGAGTGCGCG-3′) harboring 
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a 5′-phosphate group when indicated, to generate a 3′-protruding double stranded DNA 
template molecule. 5 nM of the labelled primer molecule and 12.5 nM of the template 
molecule were incubated with purified Polλ (500 nM), MnCl2 (0.1 mM), and either 
increasing concentrations of dGTP (10, 25, 50, 100 and 500 nM) for efficiency assays or 500 
nM of the indicated dNTPs for fidelity assays. In each case, the final reaction volume (20 μl) 
contained 1X reaction buffer and was incubated at 30°C for 60 min. Reactions were stopped 
by the addition of loading buffer and extension products were analyzed as described above.
2.9 Extrachromosomal NHEJ repair assay
The extrachromosomal substrate preparation and NHEJ repair assays were carried out as 
described previously [24]. Briefly, 285-bp linear DNA fragments were generated by PCR 
amplification with primers 5′-CAAGTGGTCCACCGTCATGGCTTAGCTGTATAG-3′ and 
5′-GCCGACCAGCGTCATGGCACACCCATCTCA-3′, digested with BstXI (New England 
Biolabs) to generate GACG3′ overhangs and purified using a Qiaquick PCR purification kit 
(Qiagen). This purified substrate (20 ng), together with 600 ng of pMAX-GFP plasmid 
(Lonza), was introduced into 2x105 Polμ-Polλ double-deficient mouse embryonic 
fibroblasts (MEFs) in a 10 μl volume by electroporation (Neon, Invitrogen) using a 1350 
V-30 ms pulse. Following electroporation, cells were incubated at 37 °C for 1 hour in fresh 
media, washed with PBS to remove untransfected substrate, and the total cellular DNA was 
harvested using a QIAamp DNA mini kit (Qiagen). Complementation of the MEF cells with 
purified proteins were carried out as described above but with the inclusion of 0.1–0.5 ng of 
purified proteins. Cells lacking both polymerases were used to ensure that all of the products 
of synthesis could be unambiguously attributed to activity of the introduced protein. Repair 
accuracy was characterized by PCR amplification of the repair products using Cy-5 labeled 
PCR primers (5′-CTTACGTTTGATTTCCCTGACTATACAG-3′ and 5′-
GCAGGGTAGCCAGTCTGAGATG-3′) and digestion with enzyme AatII (New England 
Biolabs). Digestion products were resolved on a 5% (wt/vol) native polyacrylamide gel, 
visualized using a Typhoon Imager (GE Healthcare) and quantified using ImageJ.
3. Results
Our previous results showed that Tel1 phosphorylates yeast PolX polymerase (Pol4) in 
response to DSB induction, such phosphorylation being relevant for a competent role of 
Pol4 during NHEJ [31]. In higher eukaryotes, Polλ constitutes the closest ortholog to yeast 
Pol4 and ATM is the central kinase operating in response to IR-induced DSBs [3]. 
Therefore, we sought to substantiate the possible conservation of PolX regulation during 
NHEJ in human cells through an evaluation of Polλ phosphorylation by ATM, a possibility 
supported by previous proteomic assays [32]. We performed in vitro kinase assays using 
purified Polλ and ATM-enriched immunoprecipitates obtained from human 293T cells 
transfected with a plasmid encoding FLAG-tagged ATM [29] and using anti-FLAG 
antibodies (Figure 1A; see Materials and Methods). These assays showed Polλ to be 
efficiently phosphorylated by the immunoprecipitates in vitro, with phosphorylation mainly 
occurring in the N-terminal region, since a mutant protein lacking the amino terminal BRCT 
and serine-proline rich domains was barely phosphorylated (Figure 1B). To confirm that 
ATM was the kinase responsible of the phosphorylation we also performed in vitro kinase 
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assays with immunoprecipitates obtained from cell lines either proficient or deficient in 
ATM using an anti-ATM antibody (Figure 1C). We found a very similar pattern of Polλ 
phosphorylation by using both ATM-proficient and ATM-deficient samples, which 
suggested that other kinase was able to catalyze the reaction (Figure 1D). Since the related 
PIKK kinase DNA-PKcs, a major player in NHEJ repair, is very abundant in human cells 
and could be contaminating the immunoprecipitates obtained by using the anti-ATM 
antibody in low stringent conditions, we evaluated the phosphorylation of human Polλ by 
DNA-PKcs. We performed kinase assays using purified human Polλ and DNA-PK complex 
that showed Polλ to be efficiently phosphorylated by DNA-PKcs in vitro in the N-terminal 
region, in agreement with our previous results (Figure 2A). Phosphorylation was undetected 
in a close homolog of Polλ in human cells, DNA Polymerase β, according to the lack of 
these N-terminal domains (Figure 2A). Western blot analysis using an antibody specifically 
recognizing phosphorylated [S/T]Q sites, the consensus sites for DNA-PKcs activity, 
confirmed human Polλ to be phosphorylated by DNA-PKcs in vitro (Figure 2B). This 
analysis also showed a significant, although not complete, decrease in phosphorylation in the 
presence of a specific DNA-PKcs inhibitor and a complete absence of phosphorylation 
following phosphatase treatment (Figure 2B), further confirming the DNA-PKcs mediated 
activity. Analysis of the amino acid sequence of human Polλ with specialized software for 
the detection of phosphorylation sites [33] identified four sites matching the [S/T]Q 
consensus motif common for all PIKKs: T188, T204, S365 and S463. Interestingly, two of 
these are localized in the N-terminal S/P-rich domain (Figure 2C), which had initially been 
suggested to be involved in the regulation of Polλ [34], and in which some cyclin-dependent 
kinase (CDK)-mediated phosphorylations have been identified [35]. [S/T]Q consensus 
motifs corresponding to T188 and T204 are highly conserved amongst orthologs, 
particularly in mammals, suggesting their relevance in Polλ function (Figure 2C). To 
identify the target site for DNA-PKcs mediated phosphorylation of Polλ, we generated 
phospho-blocking mutant proteins in which these threonine residues were substituted by 
alanines (Polλ-T188A and Polλ-T204A, respectively), thereby eliminating the 
corresponding phosphorylation sites. Western blot analysis with [S/T]Q phospho-specific 
antibodies (Figure 2B) and in vitro kinase assays using these purified phospho-blocking 
mutant proteins (Figure 2D) showed a strong reduction in Polλ-T204A phosphorylation 
with respect to wild-type protein, indicating that T204 residue was the principal target for 
DNA-PKcs mediated phosphorylation. In vitro kinase assays on a peptide-array of human 
Polλ covering its N-terminal sequence, including BRCT and S/P-rich domains, also 
confirmed this finding (Figure 2E). Of note, peptide-array also detected DNA-PKcs 
mediated phosphorylation sites out of the [S/T]Q consensus motif, which could reflect either 
non-specific phosphorylatable residues, detected as false positives, or non-consensus sites 
for DNA-PKcs phosphorylation. Taken together, these results demonstrate that human Polλ 
can be phosphorylated in vitro by both ATM and DNA-PKcs, with T204 being arguably the 
main target for such modification.
Given the role of Polλ in NHEJ and the newly identified phosphorylation at T204 residue, 
we proceeded to investigate if such phosphorylation occurs in vivo. To determine this, we 
generated rabbit polyclonal antibodies against phosphorylated T204, from which phospho-
specific antibodies were partially purified. Phospho-specific enriched antibodies (pT204) 
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preferentially detected Polλ T204 phosphorylation as demonstrated by using either purified 
peptides (Figure 3A) or purified Polλ after in vitro kinase assays with DNA-PKcs (Figure 
3B). Importantly, this pT204 antibody was also able to detect T204 phosphorylation in vivo 
in protein extracts obtained from 293T cells overexpressing FLAG-Polλ subjected to 
ionizing radiation (IR) (Figure 3C). However, T204 phosphorylation was undetectable in 
non-irradiated cells or when cells overexpressed the phospho-blocking FLAG-Polλ T204A 
mutant protein (Figure 3C). All these results validated our phospho-specific antibody to be 
used in the detection of T204 phosphorylation in vivo. Accordingly, we analyzed T204 
phosphorylation in a time course experiment after DSB induction with IR. Human 293T 
cells overexpressing FLAG-tagged Polλ were left untreated or treated with IR and collected 
at different times after DSB induction. Protein extracts were analyzed by Western blotting 
with the pT204 antibody, which confirmed that Polλ phosphorylation at T204 residue was 
triggered in vivo in response to DSB induction (Figure 3D). In agreement with this result, 
slower-migrating form(s) of FLAG-Polλ, which represented phosphorylated Polλ, became 
more abundant shortly after irradiation (Figure 3D). It should be noted that a fraction of 
Polλ was already phosphorylated in the absence of irradiation, in agreement with the fact 
that Polλ can also be phosphorylated by other kinases [35]. To determine whether ATM 
and/or DNA-PKcs were involved in Polλ T204 phosphorylation after IR-induced DSBs we 
pre-treated cells with specific inhibitors of DNA-PKcs (NU7441, DNA-PKi) or ATM 
(KU55933, ATMi) and then analyzed the effect of such treatment on T204 phosphorylation 
one hour after DSB induction (Figure 3E). Whereas pre-incubation with DNA-PKi had 
apparently no effect, ATMi severely reduced T204 phosphorylation triggered by IR, 
indicating that DSB-induced phosphorylation of Polλ in vivo was mainly mediated by 
ATM. This result was corroborated in a time course experiment in which cells were pre-
treated with ATMi and/or DNA-PKi (either independently or together), subjected to IR and 
finally analyzed by immunoblotting to detect T204 phosphorylation at several times after 
DSB induction (Figure 3F and 3G). As shown in Figure 3F, this analysis confirmed the 
strong inhibitory effect of ATMi treatment on T204 phosphorylation (Figure 3F and 3G). In 
the presence of ATMi alone or both inhibitors together T204 phosphorylation was almost 
undetected until 12 h after irradiation, and became evident 24 h after irradiation (Figure 3F 
and 3G). On the contrary, the treatment with DNA-PKi had no apparent effect on T204 
phosphorylation. Collectively, these results demonstrate that following DSB induction in 
vivo human Polλ is phosphorylated at T204 principally by ATM.
Having demonstrated that Polλ is phosphorylated at T204 after DSB induction in vivo we 
then sought to determine the physiological role of this phosphorylation during NHEJ by 
analyzing the effect of the phospho-blocking T204A mutation. To rule out any defects in the 
catalytic activity of the polymerase due to the T204A mutation, we first assayed such 
activity in vitro using purified wild-type and phospho-blocking mutant DNA polymerases 
(Figure 4). Both proteins showed similar DNA polymerization activity on gapped DNA 
substrates (Figure 4A) and NHEJ substrates resembling those preferentially managed by 
Polλ in vivo (Figure 4B) [24], indicating that the mutation does not have deleterious effects 
on the catalytic activity of Polλ. Conversely, in vitro polymerization activity of a mutant 
protein in which T204 residue was changed to a glutamic acid residue (T204E), trying to 
mimic phosphorylation modification, showed a decreased DNA polymerization activity in 
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vitro, especially in NHEJ reactions (Figure 4). Since T204 residue is far from the catalytic 
center of Polλ, this result suggested a defect in the global conformation of T204E mutant 
protein in solution with respect to wild-type Polλ, which was supported by thermal shift and 
partial proteolysis assays (Supplemental Figure 1A and 1B). The fidelity of the 
polymerization reactions carried out by all the proteins and the strict requirement for 
downstream 5′-phosphate groups in the gapped DNA molecules used in the assays were 
similar (Figure 4C).
We next analyzed the sensitivity of cells deficient in Polλ to IR-induced DSBs. Since POLL 
deficient cells are only mildly sensitive to IR [24], survival assays in response to IR were not 
suitable for this purpose. Consequently, we decided to analyze the time course of 53BP1 foci 
disappearance after DSB induction with a high dose of IR, in order to generate DSBs with 
complex DNA ends that would require some processing, likely including DNA gap-filling 
synthesis, before ligation. 53BP1 is an important positive regulator of NHEJ-mediated DSB 
repair and, given that the number of 53BP1 foci correlates well with the number of breaks 
[36,37], their quantification following DSB induction constitutes a well-established 
procedure in the monitoring of the NHEJ repair process in vivo. Time course experiments 
were performed in human U2OS cells depleted or not of endogenous Polλ by using siRNA 
(Figure 5A and 5B). Under these experimental conditions, the number of 53BP1 foci 
observed in Polλ-depleted cells was significantly higher than that observed in cells 
expressing a control luciferase siRNA in all analyzed conditions after irradiation (Figure 5B 
and 5C), indicating that the absence of Polλ results in a defect in the repair of IR-induced 
DSBs. Since IR produces a wide variety of DNA ends at the breaks, not all requiring Polλ 
activity for repair, we sought to determine the role of T204 phosphorylation in the repair of 
DSBs by using an experimental assay leading to more homogeneous DSBs. We took 
advantage of a recently described cellular assay to specifically measure Polλ-dependent 
repair of a defined DNA end structure in vivo (Figure 6A) [24]. According to the 
specialization of Polλ for filling gaps longer than 1 nt during NHEJ, DNA ends that align to 
generate a 2 nt gap substrate are repaired by less accurate polymerase-independent means in 
MEF cells deficient in both Polλ and Polμ, and the ability to perform accurate repair is 
recovered upon complementation with wild-type Polλ (Figure 6B) [24]. We first 
complemented MEFs deficient in these polymerases with increasing amounts of wild-type 
Polλ to identify levels of Polλ that were sub-saturating (Figure 6B) [24], and then 
determined that when assessed under these conditions, the Polλ-T204A phospho-blocking 
mutant protein was 3-fold less effective than the wild-type Polλ in complementation of these 
deficient MEFs (Figures 6B and 6C). Given that T204A mutation was not disadvantageous 
for Polλ DNA synthesis capability in vitro, these results indicate that T204 availability can 
be required for an efficient Polλ-dependent gap-filling DNA synthesis during the NHEJ 
repair in vivo.
To gain further insight into the molecular role of T204 phosphorylation during NHEJ we 
investigated the protein-protein interactions between Polλ and NHEJ core factors. Recent 
proteomic analyses have identified both Ku80 and DNA-PKcs as the principal partners of 
Polλ in human cells [38], a finding in agreement with the interaction of Polλ with Ku:DNA 
complexes in vitro [20,23]. We performed immunoprecipitation (IP) assays using anti-FLAG 
antibody and 293T cells overexpressing FLAG-Polλ that had previously been subjected or 
Sastre-Moreno et al. Page 11
DNA Repair (Amst). Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
not IR-induced DSBs. Treatment with the broad-spectrum nuclease benzonase was included 
during the immunoprecipitation to rule out bridging of these proteins by DNA. As shown in 
Figure 7A, an efficient co-precipitation of both Ku80 or DNA-PKcs together with FLAG-
Polλ could be observed both in irradiated and non-irradiated cells, indicating their 
interaction in vivo. Notably, the interaction of Polλ with Ku80 or DNA-PKcs was very 
specific, since other NHEJ factor such as XRCC4 did not precipitate in the same 
experimental conditions (Figure 7A). Although it has been reported that the BRCT domain 
is the essential domain for human Polλ interaction with the Ku complex in vitro [20,23], the 
analysis of such interaction using different deletion mutants of Polλ in the absence of DNA 
indicated that the presence of the S/P-rich domain was also a requirement for an efficient 
Polλ-Ku80 association (Figure 7B). Proximity ligation assays (PLA) in human U2OS cells 
confirmed the interactions detected by co-immunoprecipitation in more physiological 
conditions (Figure 7C). We also used these PLA assays to analyze the putative effect of 
Polλ-T204A mutation on the interaction with Ku80, representative of DNA-PK complex, in 
response to IR-induced DSBs. We detected robust PLA signals of Ku80 and Polλ in cells in 
the absence of irradiation, in agreement with previous co-immunoprecipitation results 
(Figure 7D). In these experimental conditions, PLA signals were similar in cells 
overexpressing either wild-type Polλ or Polλ-T204A (Figure 7D). Interestingly, following 
DSB induction, we observed a significant decrease (around 15%) in the co-localization of 
Ku80 and Polλ specifically in cells overexpressing Polλ-T204A, but not in those 
overexpressing wild-type Polλ (Figure 7D). Overall, these results indicate that T204 
phosphorylation is important in the maintenance of Ku80-Polλ association after DBSs in 
vivo and support its relevance for optimal NHEJ repair.
4. Discussion
In response to DNA DSBs hundreds of proteins are phosphorylated by PIKK kinases ATM 
and DNA-PKcs. ATM is a key transducer of the DSB response [3] and DNA-PKcs is a 
major player in the regulation of NHEJ process [39], the principal pathway to repair DSBs in 
human cells [4]. Paradoxically, despite compelling evidence demonstrating that many NHEJ 
factors are phosphorylated by ATM and/or DNA-PKcs both in vitro and after DSBs 
induction in vivo [11-14], only a few of these post-translational modifications have been 
demonstrated to be functionally relevant for NHEJ process [14-18,39]. In the present study, 
we gained insight into the NHEJ mechanism by describing a novel regulation of human 
Polλ by ATM-mediated phosphorylation. We show that human Polλ is required for the 
repair of IR-induced DSBs in vivo and that Polλ phosphorylation may facilitate Polλ-
mediated gap-filling DNA synthesis during NHEJ.
We have identified threonine 204 (T204) as the main target in Polλ for ATM/DNA-PKcs 
dependent phosphorylation in vitro. This residue is located in a serine-proline rich (S/P-rich) 
region that acts as a linker between the independent globular modules formed by N-terminal 
BRCT and C-terminal catalytic domains [22]. S/P-rich region had initially been suggested as 
acting as a regulation domain target for post-translational modifications [34], and, indeed, 
contains residues that are phosphorylated by cyclin-dependent kinases [35]. Our in vitro 
kinase assays have also detected DNA-PKcs phosphorylation sites in the S/P-rich region not 
having the [S/T]Q consensus motif. Thus, some of the peptides containing the two 
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consecutive Ser residues S42 and S43, and some of those containing T221, S222 and/or 
S230 can be also targeted by DNA-PKcs in vitro. This could be a consequence of the 
particular abundance in serine/threonine residues of this region, which, when followed by 
hydrophobic amino acids, can also be targeted by DNA-PKcs, as reported in other NHEJ 
factors [11,12,39,40]. Further studies will be required to assess the impact of the putative 
phosphorylation at these non-consensus sites in Polλ function. Although different crystal 
structures of human Polλ have been resolved [25,41], the S/P-rich domain is not included, 
probably due to its high degree of flexibility or disordered nature. Intrinsically disordered 
regions do not form fixed structures under physiological conditions, and carry out important 
regulatory functions [42]. The presence of phosphorylation sites in these flexible regions is 
common among NHEJ proteins, probably due to the fact that such flexibility facilitates their 
access to the active site of large kinases such as ATM or DNA-PKcs [43-45]. On the basis of 
its location, it can be hypothesized that Polλ T204 phosphorylation could generate protein 
conformational changes relevant to either its recruitment to DSBs or its assembly with 
DNA-bound DNA-PK complex during NHEJ repair process. In agreement to this second 
possibility, we have detected a solid interaction between Polλ and DNA-PKcs or Ku80, 
which is also corroborated by recent proteomic analyses [38]. The regulation of Polλ-DNA-
PK interaction at DSBs through Polλ phosphorylation would be useful and in agreement 
with the pivotal role of DNA-PK complex in the coordination of NHEJ process conforming 
to specific DNA end configurations [46]. In an attempt to address the conformational change 
hypothesis we characterized the phospho-mimetic mutant Polλ T204E. Both thermal shift 
and partial proteolysis assays indicate that T204E mutation modifies Polλ global 
conformation. We observed that this mutation causes a decrease in the activity of Polλ using 
NHEJ substrates in vivo (Supplemental Figure 1C), which is in contrast with results 
indicating that T204 phosphorylation stimulates NHEJ and DSB repair in vivo. Since the 
T204E mutation causes a similar defect in NHEJ assays in vitro, where only the protein and 
DNA substrates are present, it is not possible to discriminate if the mutation is mimicking 
phosphorylation modification in vivo or not, and the results obtained with T204E mutant are 
not very conclusive. In any case, they do reinforce the relevance of modifications affecting 
T204 amino acid residue to modulate the activity of Polλ during NHEJ. Further structural 
analysis would help to clarify this point.
Despite the fact that Polλ/DNA-PK association is also detected in the absence of DSB 
induction, we have observed that Polλ T204A phospho-blocking mutant protein displays a 
significant defect in its association with Ku80 specifically when DSBs are induced with IR. 
Although the defect is relatively mild, it cannot be ruled out the effect of strong 
overexpression of Polλ proteins in our experiments, that could be to some extent masking 
the real effects of mutation. In any case, the slight reduction in the Polλ/DNA-PK 
interaction caused by the phospho-blocking mutation T204A may reflect the fact that the 
participation of Polλ can be restricted to the repair of a specific subset of DNA end 
configurations, according with its substrate specificity [24]. This could also explain why 
Polλ defective cells are not highly sensitive to IR [24]. Comparable defects have been 
reported in other proteins, such as ATM kinase itself or Artemis nuclease, that specifically 
participate in the repair of a fraction of DSBs generated by IR, shown to be linked to 
heterochromatic regions (HC-DSBs) [47-50]. In this context, ATM activation is necessary to 
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phosphorylate some substrates like H2AX or KAP1, which would relax chromatin 
compaction allowing the access of repair proteins to HC-DSBs [47,48]. Another possible 
scenario is the repair of blocked DNA ends, that also requires specifically the activity of 
ATM [51]. According to our results, phosphorylation of Polλ at T204 residue in vivo strictly 
requires ATM activity and may facilitate NHEJ repair. The novel functional interaction 
between ATM and Polλ in the response to IR-induced DSBs suggests a participation of 
Polλ in the repair of some of these specially difficult to repair DSBs. Future studies 
examining the impact of Polλ and its ATM-mediated phosphorylation with HC-DSBs or 
blocked DSBs will be required to consolidate these findings.
Our work shows that Polλ T204 phosphorylation may fluctuate and is principally regulated 
by ATM in time after DSB induction. Our assays show that whereas T204 phosphorylation 
after IR-induced DSBs is dramatically reduced in the presence of an ATM inhibitor, this 
decrease does not occur in the presence of a DNA-PKcs inhibitor. This is in contrast with 
our results in vitro showing the efficient phosphorylation of Polλ either using ATM-deficient 
protein extracts or directly purified DNA-PKcs, that would fit well with a role of Polλ in 
canonical NHEJ [8,23,24,26]. Of note, it is possible, but difficult to be measured, a degree of 
functional redundancy of phosphorylation by ATM and DNA-PKcs in vivo, as occurs in 
other NHEJ factors [13,14], including DNA-PKcs itself [39], or in apical proteins during the 
DDR [52,53]. In addition, it is worth noting that the lower contribution of DNA-PKcs to 
Polλ phosphorylation observed in vivo after IR-induced DSBs could be underestimated due 
to the crosstalk between ATM and DNA-PKcs [53,54] and the compensation effects that 
may appear to preserve genomic integrity, which are also difficult to measure. In this regard, 
it has been recently reported how the loss of DNA-PKcs function by the use of specific 
inhibitors leads to hyper-activation of ATM [55]. On the other hand, the strong decrease of 
T204 phosphorylation generated by ATM inhibitor could be not only caused by direct 
inhibition of ATM kinase activity, but also due to a collateral effect on the activity of DNA-
PKcs, one of the targets of ATM after IR-induced DSBs [54]. In any case, after the treatment 
with the ATM inhibitor alone we observe that T204 phosphorylation strongly increases at 
late times after IR-induced DSBs, in agreement with the fact that inhibition of ATM retards 
repair of the chemically complex DSBs that require DNA-PKcs [56]. Intriguingly, when we 
used both ATM and DNA-PKcs specific inhibitors together, we could observe a similar 
effect in T204 phosphorylation at late times after IR-induced DSBs. A plausible explanation 
is the possible participation of the third DDR-related PIKKs, ATR, which might compensate 
the lack of the activity of the other two kinases. According with such a possibility, it has 
been reported that ATR kinase activity can be important for survival after IR in G1 phase 
cells, in which it could contribute to DSB repair in the absence of homologous 
recombination repair [57]. By integrating our results with previous findings suggesting 
distinct NHEJ sub-pathways to repair different types of DSBs with different levels of 
complexity and complementarity at their ends [23,24,53,56,58], we propose a model in 
which phosphorylation of Polλ by ATM facilitates Polλ recruitment to a subset of DNA-PK 
bound DSBs, thereby avoiding superfluous competition with other NHEJ polymerases 
(Figure 8). This might be postulated as a way to make highly accurate Polλ the first choice 
to repair DSBs having clean and complementary ends with the minimal loss of genetic 
information [24]. ATM-mediated phosphorylation of Polλ could be also required for those 
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complex DSBs whose repair has been shown to be completely dependent on ATM activity 
[47-51] (Figure 8). Of note, if ATM is not able to phosphorylate Polλ, DNA-PKcs might 
perform such reaction at the breaks, resulting in the same biological effect (Figure 8). Future 
work will be required to address the precise role and relative contribution of ATM and DNA-
PKcs to the regulation of Polλ mediated by phosphorylation at its T204 residue, likely a 
complex task taking into account the functional interplay of both kinases.
In summary, our findings provide important insight into how human Polλ is regulated by 
ATM after IR-mediated DSB induction and clearly indicates that the phosphorylation of 
Polλ at T204 is undeniably beneficial for DSB repair in vivo. Phosphorylation-dependent 
enhancement of Polλ activity possibly occurs through conformational changes of the protein 
that favor its interaction with other NHEJ proteins at a specific subset of DNA end 
configurations, according to its substrate specificities.
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Figure 1. Phosphorylation of human Polλ by ATM-enriched immunoprecipitates in vitro.
(A) ATM was immunoprecipitated from 293T cells that were transfected with a FLAG-ATM 
encoding plasmid [29], and ATM was detected in the immunoprecipitates by Western 
blotting. (B) ATM-enriched immunoprecipitates were incubated with purified Polλ proteins 
in the presence of [γ-32P]-ATP as indicated and samples were analyzed by SDS PAGE 
followed by Coomassie blue staining (CBS, left) and autoradiography (right). PolλΔBSP 
indicates a Polλ deletion mutant lacking the two amino terminal domains (BRCT and S/P-
rich). The position of purified Polλ proteins used in the assay is indicated on the right. 
Asterisks indicate the electrophoretic mobility of heavy and light immunoglobulin chains 
used in the immunoprecipitation of FLAG-ATM fusion protein. (C) Untagged ATM was 
immunoprecipitated from G361 (ATM-proficient) or HT144 (ATM-deficient) cell lines 
using monoclonal anti-ATM antibody (see Materials and Methods). (D) ATM-enriched 
immunoprecipitates were used in kinase assays as described in (B).
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Figure 2. Human Polλ is phosphorylated by DNA-PKcs in vitro at T204
(A) Kinase assay using DNA-PK complex and purified recombinant Polλ proteins. Proteins 
were incubated with [γ-32P]ATP with (+) or without (-) purified DNA-PK as indicated and 
samples were analyzed by SDS PAGE followed by Coomassie blue staining (CBS, left) and 
autoradiography (right). The position of the proteins used in the assay is indicated. PolλΔBSP 
indicates a Polλ deletion mutant lacking the two amino terminal domains (BRCT and S/P-
rich). Autophosphorylated DNA-PKcs on the autoradiogram is shown as an internal control 
in the kinase assay that represents equal kinase loading in all the samples tested. Polβ is 
shown as a control of Polλ phosphorylation specificity. Asterisks mark the position of 
bovine serum albumin. (B) Kinase assay and analysis of DNA-PKcs mediated Polλ 
phosphorylation by immunoblotting with anti-phosho[S/T]Q specific antibodies. The 
indicated purified Polλ proteins were incubated with DNA-PK, ATP, DNA-PKcs inhibitor 
NU7441 and A-phosphatase as indicated, and then analyzed by SDS-PAGE followed by 
Western blotting using a specific antibody for phosphorylated [S/T]Q sites. The position of 
phosphorylated Polλ and autophosphorylated DNA-PKcs are indicated. Ponceau staining of 
the purified proteins used in the assay is also shown (lower panel). (C) Schematic of human 
Polλ domain organization with main PIKK-dependent phosphorylation sites indicated. 
Boundaries of the different domains (BRCT, S/P-rich and catalytic) are indicated. PIKK-
dependent phosphorylation sites located in the S/P-rich domain are marked in bold; Bottom: 
Sequence alignment of the 175–216 amino acid region of Polλ highlighting the conservation 
of PIKK consensus sites across species (white over black background). Threonine residues 
that are part of these sites are indicated, as are residues conserved in all species (grey boxes). 
(D) Single and double threonine (T) to alanine (A) Polλ phospho-blocking mutants were 
generated by mutations at T188 and T204 as indicated, and in vitro kinase assay with 
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purified DNA-PK was performed as described in A). Autoradiography shows 
phosphorylated Polλ and autophosphorylated DNA-PKcs in the kinase assay (upper panel). 
Coomassie blue staining (CBS) of the purified proteins used in the assay is also shown 
(lower panel). Band intensities were quantified using ImageJ and phosphorylation of 
mutants is indicated as the percentage of phosphorylation with respect to wild-type Polλ. 
(E) Kinase assay on peptide-scanning arrays covering N-terminal BRCT and S/P-rich 
domains using purified DNA-PKcs. Peptides containing conserved T204 are shown (marked 
with a black box) and their sequence is listed below the array. Other putative sites for DNA-
PKcs targeting out of the [S/T]Q consensus motif are also indicated with grey boxes, and 
peptide sequences containing them are listed below the array.
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Figure 3. Human Polλ T204 is phosphorylated by ATM and DNA-PKcs in vivo in response to IR-
induced DSBs
(A) T204 phospho-specific antibody (pT204) preferentially recognizes phospho-T204 (p) 
over non-phospho T204 (np) peptide. (B) Purified wild-type Polλ and phospho-blocking 
PolA-T204A proteins (250 ng) were assayed for DNA-PKcs kinase activity in vitro 
(Materials and Methods). T204 phosphorylation was detected with the pT204 phospho-
specific antibody (IB). Total protein was visualized by Coomassie blue staining (CBS). 
Quantification of the corresponding bands was performed by using ImageJ. The ratio 
IB/CSB for each sample and the fold increase of T204 phosphorylation is indicated. (C) 
293T cells transfected with FLAG-empty (ev), FLAG-POLL wild-type or FLAG-POLL 
T204Aplasmid were mock irradiated or irradiated with 10 Gy of IR and collected 1 h after 
irradiation. Cell extracts were obtained and proteins analyzed by SDS-PAGE and Western 
blotting for the indicated proteins. A representative experiment is shown. (Bottom) 
Quantification of T204 phosphorylation observed in two independent experiments. Band 
intensities were quantified using ImageJ and phosphorylated T204 (pT204) is represented as 
pT204/Total Polλ ratio. Statistical significance was determined with one-tailed Mann-
Whitney test, *** p<0.001 (D) 293T cells transfected with a plasmid encoding wild-type 
FLAG-POLL were mock irradiated or irradiated with 10 Gy of IR and collected at the 
indicated time post-irradiation. Whole cell extracts were obtained and FLAG-Polλ 
Sastre-Moreno et al. Page 23
DNA Repair (Amst). Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
phosphorylation was analyzed by Western blot using anti-FLAG antibody. The same 
samples were also immunoblotted using Polλ-T204 phospho-specific antibody (pT204) as 
described in Materials and Methods, Polλ antibody (total Polλ control), tubulin antibody 
(loading control), phospho-Ser2056 DNA-PKcs antibody (control of IR-mediated DSB 
induction) and DNA-PKcs antibody (total DNA-PKcs control), as indicated. Asterisk 
indicates putative faster migrating untagged Polλ, representing either endogenous Polλ or 
some protein degradation, or a cross-reactive band. (E) Effects of ATM and/or DNA-PKcs 
inhibition on Polλ T204 phosphorylation. Human 293T cells were pre-treated with vehicle 
DMSO, the specific DNA-PKcs inhibitor NU7441 (2.5 or 5 μM) or the specific ATM 
inhibitor KU55933 (2.5 or 5 μM). One hour after addition of inhibitors, cells were left 
untreated or irradiated with 10 Gy of IR and collected 1 h after irradiation. Whole cell 
extracts were prepared and blotted for phosphorylated T204 (pT204), FLAG-Polλ (FLAG) 
and tubulin as described in Materials and Methods. The experiment was repeated twice with 
similar results. (F,G) Kinetics of T204 phosphorylation in human 293T cells treated with 
vehicle DMSO, the specific DNA-PKcs inhibitor NU7441 (5 μM), the specific ATM 
inhibitor KU55933 (5 μM) or both inhibitors together (5 μM each). One hour after addition 
of the inhibitor/s, cells were left untreated or irradiated with 10 Gy of IR and collected at 
indicated times after irradiation. Whole cell extracts were prepared and blotted for 
phosphorylated T204 (pT204), FLAG-Polλ (FLAG) and tubulin. Quantification of relative 
band intensities was carried out using ImageJ software. Levels of pT204 were normalized to 
total Polλ protein. Tubulin was used as a loading control. The experiment was repeated 
twice with similar results. A representative experiment is shown in (G).
Sastre-Moreno et al. Page 24
DNA Repair (Amst). Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4. in vitro characterization of PolA-T204A and PolA-T204E phospho-mutant proteins
Polymerization assays were carried out as described in Materials and Methods. Specific 5′-
[γ-32P]-labelled gapped (A) and NHEJ (B) DNA substrates were incubated with 50 nM of 
either purified recombinant wild-type Polλ, Polλ-T204A phospho-blocking or Polλ-T204E 
phospho-mimic mutants in the presence of the indicated concentrations of ddGTP, to ensure 
that polymerization events were restricted to a +1 nt insertion. After 30 min at 30°C, primer 
extension was analyzed by 8M urea/PAGE and autoradiography. The positions of the 
labelled primer (p) and the +1 nt extension products are indicated. Statistical significance of 
the different kinetics of PolA-T204E mutant with respect to wild-type Polλ was determined 
with a non-linear regression fit using PRISM software, *** p<0.001. (C) Specific 5′-
[γ-32P]-labelled NHEJ DNA substrates, with or without a downstream 5′-phosphate group 
were incubated with 50 nM of either purified recombinant wild-type Polλ, Polλ-T204A or 
Polλ-T204E mutants in the presence of the indicated dNTPs and processed as in (A). The 
positions of the labelled primer (p) and the +1/+2 nt extension products are indicated.
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Figure 5. Polλ is required for an efficient repair of IR-induced DNA DSBs in vivo.
(A) POLL silencing in human U2OS cells. U2OS cells were doubly transfected with either 
siR-NA-POLL or control siRNA-luciferase (Luc) as described in Materials and Methods. 
Seventy-two hours later cells were collected and whole cells extracts obtained. Silencing 
efficiency was confirmed by Western blotting using anti-Polλ antibody. Electrophoretic 
mobility of human Polλ is indicated. (B) Dynamics of 53BP1 foci disappearance in cells 
silenced for POLL expression in response to IR-induced DSBs. U2OS cells were doubly 
transfected with either control luciferase siRNA or POLL siRNA. Seventy-two hours later, 
cells were irradiated with 10 Gy of IR, collected at the indicated times and co-stained for 
53BP1 (green) and DAPI (blue). 53BP1 foci were scored for ≥ 50 cells per condition, via 
blind counting. Results represent the mean and standard error of the mean of three 
independent experiments. Statistical significance was determined by two-way ANOVA test 
with Bonferroni post-test correction, **p<0.01, ***p<0.001. (C) Representative image of 
the immunofluorescent identification of 53BP1 foci scored in (B) visualized in a 
fluorescence microscope. High-resolution z-stack images were obtained and then rendered 
into a 2D image showing DAPI stained nuclei (blue) and 53BP1 foci (green).
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Figure 6. Extrachromosomal assay to specifically measure PolA-dependent NHEJ in vivo.
(A) Description of the extrachromosomal DSB repair assay. A linear DNA fragment with 
GACG3′ overhangs can align to generate a 2-nt gap with 5′-phosphate ends (described in 
cartoon). These DNA substrates were introduced into Polu-Polλ double-deficient mouse 
embryonic fibroblasts (MEFs) that were also complemented with either wild-type Polλ or 
T204A phospho-blocking mutant purified proteins. Repair products were recovered and 
amplified. Amplified products were subjected to restriction enzyme digestion using an 
enzyme (AatII) diagnostic for accurate (PolA-mediated) repair. (B) The GACG3′ NHEJ 
substrates were introduced into the polymerase-deficient MEFs together with increasing 
amounts (0.1, 0.2, and 0.5 ng) of purified Polλ or PolA-T204A proteins to identify the 
experimental conditions where Polλ was not saturating, and thus best-able to respond to 
phosphorylation-dependent regulation of activity. The percentage of junctions formed after 
PolA-mediated accurate synthesis is indicated. (C) The GACG3′ NHEJ substrates were 
introduced into the polymerase-deficient MEFs together with the lowest dose (0.1 ng) of 
purified proteins. The percentage of junctions formed after PolA-mediated fill-in of the 2 nt 
gap is indicated below the panels and the quantification of these experiments in shown in the 
plot. Results represent the mean and standard error of the mean of three independent 
experiments. Mean recovery efficiencies were assessed as significantly different using one-
tailed Mann-Whitney test, **p<0.01.
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Figure 7. Polλ interacts with Ku80 and DNA-PKcs
(A) 293T cells transfected either with FLAG-empty or FLAG-POLL plasmids were mock 
irradiated or irradiated with 10 Gy of IR to induce nonspecific DSBs. One hour later, whole 
cell extracts were prepared and FLAG-Polλ was immunoprecipitated with anti-FLAG 
antibody (IP) in the presence of 20 U/mL benzonase and immunoblotted (IB) with the 
indicated antibodies. Input samples are 10% (v/v) with respect to IP samples. (B) 293T cells 
transfected with either FLAG-empty vector or plasmids encoding different FLAG-POLL 
deletion variants (a scheme is shown at top) were treated as in (A). FLAG-tagged proteins 
were immunoprecipitated (IP) in the presence of 20 U/mL benzonase, run in 4-20% gradient 
gels and immunoblotted (IB) as indicated. Input samples are 10% (v/v) with respect to IP 
samples. (C) Proximity ligation assays were performed to confirm in situ the interactions 
described in (A) and (B). U2OS cells overexpressing FLAG-Polλ were irradiated with 2 Gy 
of IR and examined 1 h after irradiation for PLA foci of FLAG (for PolA) and the indicated 
proteins by immunofluorescence. Nuclei were counterstained with DAPI and the PLA 
signals (red) were visualized in a fluorescence microscope (scale bars, 7.5 μm). (D) U2OS 
cells overexpressing either FLAG-Polλ or FLAG-Polλ-T204 were mock irradiated or 
irradiated with 2 Gy of IR, and examined 1h after irradiation for PLA foci of FLAG (for 
PolA) and Ku80 by immunofluorescence as described in (C). The plot shows quantification 
of PLA signal per nucleus from three independent experiments (at least 150 cells scored). 
Statistical analysis was performed first with Kolmogorov-Smirnov test, which indicates the 
non-parametric distribution of samples, and with Kruskal–Wallis One-Way test and Dunn's 
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post-test correction, ** p<0.01 compared to wild-type Polλ transfected cells. Lines denote 
mean values.
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Figure 8. A model of IR-induced phosphorylation of Polλ T204 during NHEJ repair
Upon DSB induction with IR, different types of DSBs, representing different levels of 
complexity at their ends, must be repaired. A pivotal step in the DDR is the recruitment and 
activation of ATM by the Mre11-Rad50-Nbs1 (MRN) complex. Once activated, ATM 
phosphorates the MRN complex, histone H2AX and DNA-PKcs, among other targets. In 
addition, it phosphorylates Polλ at T204 residue, necessary for the repair of a subset of 
DSBs having either clean or complex DNA ends. T204 phosphorylation facilitates the 
formation of a stable complex of Polλ and DNA-bound DNA-PK, favoring an efficient 
Polλ-mediated gap-filling. Notably, in the absence of ATM, DNA-PKcs could also 
phosphorylate Polλ at T204, presumably with the same biological effect (indicated with a 
dotted blue arrow). Polλ is represented as a protein containing two globular domains joined 
by a linker representing the S/P-rich domain. Phosphorylation by ATM is indicated with 
orange arrows and circles.
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